Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
about
Prophylactic non-steroidal anti-inflammatory agents for the prevention of cystoid macular oedema after cataract surgeryProphylactic non-steroidal anti-inflammatory agents for the prevention of cystoid macular oedema after cataract surgeryMoving Past Anti-VEGF: Novel Therapies for Treating Diabetic RetinopathyEfficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.Prophylactic non-steroidal anti-inflammatory drugs for the prevention of macular oedema after cataract surgery.Comparison of the efficacy and patients' tolerability of Nepafenac and Ketorolac in the treatment of ocular inflammation following cataract surgery: A meta-analysis of randomized controlled trials.Aqueous, oil, and ointment formulations of ketorolac: efficacy against prostaglandin E2-induced ocular inflammation and safety: a technical note.Ketorolac Tromethamine Spray Prevents Postendotracheal-Intubation-Induced Sore Throat after General Anesthesia.A review of the use of ketorolac tromethamine 0.4% in the treatment of post-surgical inflammation following cataract and refractive surgery.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgeryTopical nonsteroidal anti-inflammatory drugs for macular edema.Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions.Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directions.Comparing the Efficacy of Ophthalmic NSAIDs in Common Indications: A Literature Review to Support Cost-effective Prescribing.Recovery after cataract surgery.The comparative efficacy and safety of topical non-steroidal anti-inflammatory drugs for the treatment of anterior chamber inflammation after cataract surgery: a systematic review and network meta-analysis.Effect of air bubble on inflammation after cataract surgery in rabbit eyes.Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac.A Prospective, Open-label Study to Compare the Efficacy and the Safety of Topical Loteprednol Etabonate and Topical Flurbiprofen Sodium in Patients with Post-Operative Inflammation after Cataract ExtractionIn vivo ocular availability of ketorolac following ocular instillations of aqueous, oil, and ointment formulations to normal corneas of rabbits: a technical note.Analgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgery.Pharmacokinetic and toxicity investigations of a new intraocular lens with a dexamethasone drug delivery system: a pilot study.Aceclofenac oil drops: characterization and evaluation against ocular inflammation.
P2860
Q24234054-3F9406C5-4903-45C5-86C6-FEE4D2CDFD43Q24244949-4C7C401A-23E1-479F-A41E-93807437E4B1Q28078199-86B8354A-5C93-4A7C-B3E2-E4AC8B3B8020Q34413000-758484B0-C788-41B9-A281-F1EE81B52082Q34543852-C6DC478A-B9EB-4155-9A94-62AAF84121D0Q36295447-50A9D0E3-C790-4A4C-8A15-66D91828B102Q37360590-28F9A529-C11A-474C-9126-FD64E55588B1Q37497091-64EF1CA4-B850-4727-80B2-292322391292Q37577420-C3B05C47-6B12-4DEF-8D71-D47BA3988E1EQ37769529-91A16FB9-DC45-4138-A3E7-7E2267D1BBD0Q37900493-A57084E8-4827-4DC9-B007-10E70F92BF44Q38162433-4335557F-8ED6-4A0E-BB17-D29897CCE8F9Q38227621-928B38F3-16F4-4D79-9797-9ABAB3DBD329Q38233855-7793EEC7-2795-4A13-830C-BF6CAEC8008EQ38366007-AE237C49-6740-4670-98B0-3C338C453074Q38816679-64AD8296-4223-405C-8EC7-479E89CD1C38Q39107181-6C327E0A-D68C-45B5-AE51-9ACA7B4C9063Q41875663-CA98BCBD-51BD-4150-A3EB-D0098E8F83E6Q42014765-68B50912-2039-415C-82C8-697EAE4DEAD4Q42102961-B725D4A5-49C2-4E58-B9C2-DE28710BA52DQ42563800-6CFC50BC-42D8-4632-BB58-73DFA9F7A5BBQ43102831-902F93FA-52FC-4E64-8CB9-7305B77B3418Q43769684-87833DDF-BE24-4445-B59E-64B5B70034FDQ48349124-4B7671B2-9F8B-475A-B56B-FF5D45E18471
P2860
Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Topical ketorolac tromethamine ...... mation after cataract surgery.
@ast
Topical ketorolac tromethamine ...... mation after cataract surgery.
@en
type
label
Topical ketorolac tromethamine ...... mation after cataract surgery.
@ast
Topical ketorolac tromethamine ...... mation after cataract surgery.
@en
prefLabel
Topical ketorolac tromethamine ...... mation after cataract surgery.
@ast
Topical ketorolac tromethamine ...... mation after cataract surgery.
@en
P2093
P1433
P1476
Topical ketorolac tromethamine ...... mation after cataract surgery.
@en
P2093
Cheetham JK
Rosenthal A
Solomon KD
P304
P356
10.1016/S0161-6420(00)00543-1
P577
2001-02-01T00:00:00Z